Cre (Ef1a Promoter, Neo), Concentrated Lentivirus

Pre-made lentiviral particles expressing sequence verified CRE recombinase under an enhanced EF1a promoter which is a strong promoter independent of tissue or cell types, and less likely to be silenced in long-term culture conditions. CRE contains a NLS (nuclear localization signal) at its N-term. This nuclear permeant CRE increases the recombination events in vivo. A Neomycin marker under RSV promoter, allows to select transduced cells for long term expression via Neomycin (G418) antibiotic.

Cre protein, from bacteriophage P1, catalyzes recombination between 34 base pair target sequences, named lox sites. Cre lentiviral particles can catalyze the jointing event in Vivo in the presence of lox sites. Purified Cre enzyme can joint individual plasmids containing lox sites.

This product constitutively expresses nuclear localized Cre enzyme in all cell types.

Suitable for non-serum cell culture and hard-to-transduced cell types, or directly used for in vivo application.

Ef1a

Neomycin (G418) antibiotic selection.

293T cells were transduced with serial dilutions of this product, harvested several days later, and genomic DNA was isolated. Copies of RRE were measured and normalized to RPP30.

Viral particles are shipped frozen on dry ice. Plasmid DNA will also be included in the shipment.

Our lentivirus are stable for at least 1 year if kept at -80 °C, avoid freeze-thaw cycle. Re-freezed unused particles should be kept at 4 °C within 3-5 days.

In PBS.

Purified into PBS solution.

Requestor is responsible for compliance with their institution's biosafety regulations. Lentivirus is generally considered BSL-2.